BILLERICA, Mass., April 27, 2017 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 42nd annual Deutsche Bank Health Care Conference at The InterContinental Hotel, 510 Atlantic Avenue, Boston. Frank Laukien, Chairman, President & CEO will participate in a "fireside chat" Q&A session on behalf of the company on Thursday, May 4th, 2017 at 8:40 AM Eastern Time.
A live audio webcast of the presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.
About Bruker Corporation
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit: www.bruker.com
Head of Investor Relations
T: +1 (978) 663 – 3660, ext. 1479
SOURCE Bruker Corporation